Roivant Sciences Ltd. (ROIV) Stock: News, Analysis, Q&A, and Insights

Investment Analysis Report: ROIV

Overview

In this investment analysis report, we will delve into the financial statements of ROIV, a company in the Health Technology sector specializing in Pharmaceuticals. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements over the past three years to gain insights into the company's ...

Technical Analysis of ROIV 2024-05-03

Overview:

In analyzing the technical indicators for ROIV over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day Moving Average (MA) has been showing an upward trend,...

Recent News & Updates

2024-05-07 14:43
Greenlight Capital Initiated a Position in Roivant Sciences (ROIV) in Q1(Insidermonkey)
2024-05-07 02:04
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare(Investorplace)
2024-05-05 08:45
Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain(Simply Wall St.)
2024-04-30 22:47
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026(Investorplace)
2024-04-24 20:00
Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis(Businesswire)
2024-04-11 23:09
10 Most Undervalued Stocks to Buy for Under $20(Insidermonkey)
2024-04-02 07:00
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million(GlobeNewswire)
2024-04-01 19:00
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million(Globenewswire)
2024-03-27 13:55
Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck(The Wall Street Journal)
2024-03-26 18:22
Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600(PR Newswire)
2024-03-26 06:22
Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600(Prnewswire)
2024-03-16 20:50
30 Biggest Biotechnology Companies in the World(Insidermonkey)
2024-03-13 19:04
10 Stocks George Soros and Insiders Are Crazy About(Insidermonkey)
2024-02-14 13:45
Do You Think the Management of Roivant Sciences (ROIV) Can Create Value?(Insidermonkey)
2024-02-14 07:13
Roivant Sciences Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-02-13 07:00
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update(GlobeNewswire)
2024-02-12 18:00
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update(Globenewswire)
2024-02-10 02:55
Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares(GuruFocus.com)
2024-01-30 16:05
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024(GlobeNewswire)
2024-01-30 03:05
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024(Globenewswire)
2023-12-27 07:05
5 High Growth International Stocks to Buy(insidermonkey)
2023-12-20 16:30
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease(GlobeNewswire)
2023-12-20 03:30
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves' Disease(globenewswire)
2023-12-14 09:00
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease(GlobeNewswire)
2023-12-13 20:00
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease(globenewswire)
2023-11-28 07:00
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential(GlobeNewswire)
2023-11-27 18:00
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential(globenewswire)
2023-11-27 13:38
5 Stocks Under $20 To Buy Now(insidermonkey)
2023-11-27 08:00
Roivant and Priovant Announce Results from Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus(GlobeNewswire)
2023-11-26 19:00
Roivant and Priovant Announce Results from Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus(globenewswire)

Page 1 of 4

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity

ROIV

Performance

Profile